1. Wu, Zhongbiao, You, Chengkun, Zhu, Zhongyan, Huang, Xinmei, Hu, Shiping. 2023. SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment. In European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 281, 427-440. doi:10.1007/s00405-023-08213-4. https://pubmed.ncbi.nlm.nih.gov/37688682/
2. Gale, Cheryl A, Leonard, Michelle D, Finley, Kenneth R, Becker, Jeff, Berman, Judith. 2009. SLA2 mutations cause SWE1-mediated cell cycle phenotypes in Candida albicans and Saccharomyces cerevisiae. In Microbiology (Reading, England), 155, 3847-3859. doi:10.1099/mic.0.033233-0. https://pubmed.ncbi.nlm.nih.gov/19778960/